"Tatsuaki;Takeda|Shiho;Sugimoto|Jun;Matsumoto|Naohiro;Iwata|Akihiko;Nakamoto|Aya Fukuma;Ozaki|Hirofumi;Hamano|Noritaka;Ariyoshi|Yoshito;Zamami|","A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases","International Journal of Clinical Pharmacy","2210-7703","2024-01-19","","","","","isVersionOf https://doi.org/10.1007/s11096-023-01687-6","38240964","001145361500002","https://ousar.lib.okayama-u.ac.jp/66563","10.1007/s11096-023-01687-6"
    "Jun;Matsumoto|Hiroyoshi;Nakamura|Su Nwe;San|Hikari;Sato|Manami;Takezawa|Ryuto;Kishi|Yutaro;Kito|Junko;Sugano|Mai;Izuki|Nao;Yanagisawa|Naoki;Ikeda|Yusuke;Saito|Yoshinori;Kato|Harumi;Yamada|Masachika;Fujiyoshi|Noritaka;Ariyoshi|","A proposed simple screening method to determine relative contributions of CYP3A4 and CYP3A5 to drug metabolism in vitro","Personalized Medicine Universe","21867070","2019-07-31","8","","41","44","isVersionOf https://doi.org/10.1016/j.pmu.2019.04.001","","","https://ousar.lib.okayama-u.ac.jp/57264","10.1016/j.pmu.2019.04.001"
    "Shogo;Watari|Motoo;Araki|Jun;Matsumoto|Kasumi;Yoshinaga|Takanori;Sekito|Yuki;Maruyama|Yosuke;Mitsui|Takuya;Sadahira|Risa;Kubota|Shingo;Nishimura|Koichiro;Wada|Yasuyuki;Kobayashi|Hidemi;Takeuchi|Katsuyuki;Tanabe|Masashi;Kitagawa|Hiroshi;Morinaga|Shinji;Kitamura|Hitoshi;Sugiyama|Noritaka;Ariyoshi|Jun;Wada|Masami;Watanabe|Toyohiko;Watanabe|Yasutomo;Nasu|","Blood concentrations of tacrolimus upon conversion from rabeprazole to vonoprazan in renal transplant recipients: Correlation with cytochrome P450 gene polymorphisms","Drug Metabolism and Pharmacokinetics","13474367","2021-10-31","40","","100407","","isVersionOf https://doi.org/10.1016/j.dmpk.2021.100407","34352707","000702719100002","https://ousar.lib.okayama-u.ac.jp/62503","10.1016/j.dmpk.2021.100407"
    "Jun;Matsumoto|Su Nwe;San|Masachika;Fujiyoshi|Ayano;Kawauchi|Natsumi;Chiba|Ran;Tagai|Ryoko;Sanbe|Shiho;Yanaka|Hiroaki;Sakaue|Yoshinori;Kato|Hiroyoshi;Nakamura|Harumi;Yamada|Noritaka;Ariyoshi|","Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro : a different effect on asunaprevir versus daclatasvir and beclabuvir","Journal of Human Genetics","1434-5161","2019-10-23","65","","143","153","isVersionOf https://doi.org/10.1038/s10038-019-0685-2","31645655","000513167200007","https://ousar.lib.okayama-u.ac.jp/58231","10.1038/s10038-019-0685-2"
    ";Su Nwe San|Jun;Matsumoto|Yumi;Saito|Masako;Koike|Hiroaki;Sakaue|Yoshinori;Kato|Masachika;Fujiyoshi|Noritaka;Ariyoshi|Harumi;Yamada|","Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro","Xenobiotica","00498254","2018-11-08","49","8","935","944","isVersionOf https://doi.org/10.1080/00498254.2018.1524947","30227770","000468066800007","https://ousar.lib.okayama-u.ac.jp/57497","10.1080/00498254.2018.1524947"
    "Jun;Matsumoto|Yumi;Kotera|Shogo;Watari|Koichi;Takeuchi|Hideo;Ueki|Toshihiro;Koyama|Koichiro;Wada|Masachika;Fujiyoshi|Yasutomo;Nasu|Noritaka;Ariyoshi|","Relevance of CYP3A5 Expression on the Clinical Outcome of Patients With Renal Cell Carcinoma","Anticancer Research","0250-7005","2021-5","41","5","2511","2521","isVersionOf https://doi.org/10.21873/anticanres.15029","33952479","000648665800021","https://ousar.lib.okayama-u.ac.jp/62038","10.21873/anticanres.15029"
    "Jun;Matsumoto|Anzu;Nishimoto|Shogo;Watari|Hideo;Ueki|Shoya;Shiromizu|Naohiro;Iwata|Tatsuaki;Takeda|Soichiro;Ushio|Makoto;Kajizono|Masachika;Fujiyoshi|Toshihiro;Koyama|Motoo;Araki|Koichiro;Wada|Yoshito;Zamami|Yasutomo;Nasu|Noritaka;Ariyoshi|","Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma","Molecular and Cellular Biochemistry","0300-8177","2022-12-26","478","8","1779","1790","isVersionOf https://doi.org/10.1007/s11010-022-04637-4","36571650","000904010400001","http://escholarship.lib.okayama-u.ac.jp/64309","10.1007/s11010-022-04637-4"